• OPEN AN ACCOUNT
Indian Indices
Sensex
83,674.92 -558.72
( -0.66%)
Global Indices
Nasdaq
50,155.23 -53.92
(-0.11%)
Dow Jones
6,964.65 1.84
(0.03%)
Hang Seng
57,686.98 36.44
(0.06%)
Nikkei 225
10,491.19 137.35
(1.33%)
Forex
USD-INR
90.60 -0.06
(-0.06%)
EUR-INR
107.84 0.20
(0.18%)
GBP-INR
123.81 0.16
(0.13%)
JPY-INR
0.58 0.00
(0.79%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
461.79599
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
10.04
15237.77
EPS(TTM)
Face Value()
Div & Yield %
84.75
2
0.7
 
( Cr)
ParticularsDec 2025 ( Cr)Sep 2025 ( Cr)Jun 2025 ( Cr)
Gross Sales528.801264.301192.70
Other Operating Income0.000.000.00
Other Income 55.3093.3059.60
Total Income584.101357.601252.30
Total Expenditure 408.50711.80653.00
PBIDT175.60645.80599.30
Interest 8.3011.702.60
PBDT167.30634.10596.70
Depreciation42.1048.1053.80
Tax26.20130.60106.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-7.90-45.50-27.20
Reported Profit After Tax106.90500.90464.10
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item106.90500.90464.10
EPS (Unit Curr.)5.9727.9725.91
EPS (Adj) (Unit Curr.)5.9727.9725.91
Calculated EPS (Unit Curr.)5.9727.9825.93
Calculated EPS (Adj) (Unit Curr.)5.9727.9825.93
Calculated EPS (Ann.) (Unit Curr.)23.89111.93103.71
Calculated EPS (Adj) (Ann.) (Unit Curr.)23.89111.93103.71
Book Value (Unit Curr.)0.000.000.00
Dividend (%)75.0075.00100.00
Equity35.8035.8035.80
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)33.2151.0850.25
PBDTM(%)31.6450.1550.03
PATM(%)20.2239.6238.91